NB
Nascent Biotech, Inc.
NBIO · OTC
$0.00 +0.00% (+$0.00)
1M -33.33%
Market Cap $34.4K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
1/9Valuation
0 /100
Expensive P/S 11,481.10x
EV/FFO N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
0 /100
Weak Net margin 44,926,500.00%
Op. margin 50,236,100.00%
FCF margin 44,936,300.00%
Quality
57 /100
Average ROA 741.27%
Asset turnover 0.00x
ROIC 213.86%
Debt
0 /100
High Int. coverage -59.09x
Current ratio 0.19x
Net debt/EBITDA N/A
Stability
5 /100
Unstable EPS volatility 283.98%
Profitable years 0
Beta 1.76x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about NBIO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Sean Carrick
Employees
2
Headquarters
North Palm Beach